Rapid transfer port productpage-image-768x464px-v2-w768h498.jpg

Extract Technology ISO 9001 Manufacturing Expansion in the UK

April 25, 2022 - The Dec Group announces a significant expansion of their Extract Technology UK ISO 9001 manufacturing facility located in Huddersfield, UK. The Bradley Junction site expansion includes the acquisition of an additional building within the current industrial complex. The expansion serves to support the growing needs of Extract Technology’s global customer base and add further efficiency to UK manufacturing operations.

Growth forecasted with our key end users as part of a collaborative approach to end-user support has led to a clear and committed expectation for Extract’s aseptic and containment pharmaceutical solutions, which includes our innovative Cell & Gene Therapy technology. Expanding capacity and optimizing manufacturing layout creates a more customer-focused environment, expands direct support for Dec Group products into the UK market, and drives further innovation of Dec Group Containment technologies.

The addition to the UK operation has been a collaborative approach with our end users, and has been developed in line with the shifting expectations of the market, this has been a learning period for our clients and we have engaged in proactive investment that will be associated, and aligned with the demands of our global partners.

The expanded operation will support reduced lead-times, and greater efficiency across all platform products, with specific focus on global customer support, this is being driven via a lean manufacturing approach and significant investment for the tools needed by the team.

Alan Wainwright, (Global MD Extract Technology) comments, “We know these critical but slightly less engineered products have a differential associated with the general operating model, as such a more focused and differentiated flow for the technology will enhance our ability to serve all our market needs at an optimal level”.

Since acquisition by the Dec Group, this is the 2nd major investment announcement in the Extract Technology business with respect to infrastructure.

Jaime Larder, Head of HR stated our growth as a company is exciting to us. We enjoy seeing the liveliness that this announcement brings to our Team and will be hiring for several positions in the coming months and looking forward to inviting new talent into our expert team.”

The Extract USA expansion will come on line late 2022, and will house a new world class manufacturing facility, this will include one of the largest NQA-1 operations in North America, servicing the needs for Nuclear Grade Isolation (including RadioPharma applications), and support our Mobile Clean Room (MCR) products.

image_2022-04-26_092549869.png

Extract Technology’s new facility located at Bradley Junction Industrial Estate